how many injections of semaglutide for weight loss Dosage Chart & Dosing Guide Semaglutide for Chronic Weight Management

As the first anti-obesity drug targeting multiple receptors, tirzepatide (Zepbound, Eli Lilly), a dual GIPR/GLP-1R agonist, was approved by the FDA in 2022

Cell Microbiol (2007) 9(5):111726

That said, there are a few differences worth knowing about

Compared to newer GLP-1 drugs, dulaglutide tends to produce more moderate results

Nerve Protection: Mecobalamin supports the synthesis of myelin, a protective sheath around nerve fibres

Individuals who are pregnant, breastfeeding, or have a history of pancreatitis, kidney failure, gallbladder disease, medullary thyroid carcinoma, MEN2 syndrome, or eating disorders should not use GLP-1 medications regardless of dose